Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Risks of Long-Acting Beta-Agonists in Achieving...
Journal article

Risks of Long-Acting Beta-Agonists in Achieving Asthma Control

Authors

Drazen JM; O'Byrne PM

Journal

New England Journal of Medicine, Vol. 360, No. 16, pp. 1671–1672

Publisher

Massachusetts Medical Society

Publication Date

April 16, 2009

DOI

10.1056/nejme0902057

ISSN

0028-4793

Associated Experts

Paul O'Byrne

Dean and Vice-President, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and clinical sciences42 Health sciences

Medical Subject Headings (MeSH)

Adrenergic beta-AgonistsAsthmaBronchodilator AgentsHumansRisk Assessment
View published work (Non-McMaster Users)
View published work (McMaster Users)